Tower Research Capital LLC (Trc) Sarepta Therapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 14,522 shares of SRPT stock, worth $1.11 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
14,522
Previous 9,151
58.69%
Holding current value
$1.11 Million
Previous $1.14 Million
54.55%
% of portfolio
0.04%
Previous 0.03%
Shares
29 transactions
Others Institutions Holding SRPT
# of Institutions
534Shares Held
85.3MCall Options Held
1.55MPut Options Held
1.35M-
Black Rock Inc. New York, NY10.3MShares$788 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$693 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$664 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$330 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$311 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $6.68B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...